home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
Arvinas Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Arvinas Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Post navigation
Previous Post
Previous
Alumis Initiates ONWARD Phase 3 Clinical Program Evaluating ESK-001, an Oral TYK2 Inhibitor, in Moderate-to-Severe Plaque Psoriasis
Next Post
Next
Revolution Medicines to Report Financial Results for Second Quarter 2024 After Market Close on August 7, 2024